Armenia joins 10 countries in the WHO European Region in achieving the regional hepatitis B control target, marking a demonstrable impact in protecting people from hepatitis B through vaccination. This achievement of Armenia has been validated by the European Technical Advisory Group of Experts on Immunization (ETAGE).
Since introducing universal newborn hepatitis B vaccination in 1999, Armenia has strengthened immunization programme, expanded protection for healthcare workers and other at-risk groups, and taken comprehensive steps to prevent mother-to-child transmission, including screening of pregnant women and timely birth-dose vaccination. A nationwide serosurvey conducted between 2023- 2025 found no cases of chronic hepatitis B among children aged 6–8 years – a powerful indication that transmission has been effectively controlled in the young children.
“This recognition is a testament to Armenia’s long-standing commitment to immunization and disease prevention,” said Ms Anahit Avanesyan, Minister of Health of the Republic of Armenia. “While we celebrate this achievement, we remain committed to sustaining high vaccination coverage and advancing to eliminate viral hepatitis as a public health threat.”
“The absence of chronic hepatitis B among young children is a remarkable public health success and an inspiring example for the WHO European Region,” said Dr Siddhartha Datta, WHO Representative in Armenia. “It demonstrates what can be achieved through strong political commitment, the dedication of health professionals and trust of the population.”
Read also
WHO together with other UN agencies and stakeholders will continue to support Armenia in sustaining this achievement and moving closer to the elimination of viral hepatitis as a public health threat.
